RESUMEN
Fluoroquinolone resistance is a growing problem that has only recently emerged in S. agalactiae. Between 2005-2007, WHONET--Argentina network evaluated levofloxacin susceptibility in 1128 clinical S. agalactiae isolates, 10 (0.9%) of which proved to be resistant. Nine of them had come from 5 hospitals (in Buenos Aires City and 4 Argentinean provinces) and recovered from urine (n=7) and vaginal screening cultures (n=2). Three strains were also resistant to macrolides, lincosamides and B streptogramins due to the ermA gene. All nine fluoroquinolone-resistant isolates bore the same two mutations, Ser79Phe in ParC and Ser81Leu in GyrA proteins. Genetic relationships were analyzed by Apal-PFGE and two clones were determined, A (n=6) and B (n=3). To our knowledge, these are the first fluoroquinolone-resistant S. agalactiae isolates detected in Latin America.
Asunto(s)
Antibacterianos/farmacología , Fluoroquinolonas/farmacología , Streptococcus agalactiae/efectos de los fármacos , Argentina , Farmacorresistencia Bacteriana , Humanos , Streptococcus agalactiae/aislamiento & purificaciónRESUMEN
Enterococcusgallinarum is intrinsically resistant to low levels of vancomycin and has been described as a colonizing microorganism causing bacteraemia and infection among immunosupresed patients. Between August 2000 and February 2001, 15 highly glycopeptide-resistant E. gallinarum isolates, one from blood and the remaining from rectal swabs, were recovered in a general hospital of Buenos Aires Province, Argentina. All isolates were characterized by biochemical assays, and displayed MICs of vancomycin in the range 16-128 mg/l and MICs of teicoplanin in the range 16-32 mg/l. In all cases, PCR analysis yield positive results for both vanC1 and vanA genes. E. gallinarum isolates were classified as two clonal types by SmaI-PFGE: clone A (n = 8) and clone B (n = 7) and both harboured a transferable vanA element.
Asunto(s)
Proteínas Bacterianas/genética , Ligasas de Carbono-Oxígeno/genética , Conjugación Genética , Enterococcus/efectos de los fármacos , Infecciones por Bacterias Grampositivas/epidemiología , Unidades de Cuidados Intensivos , Resistencia a la Vancomicina , Antibacterianos/farmacología , Argentina/epidemiología , Elementos Transponibles de ADN , Desoxirribonucleasas de Localización Especificada Tipo II/metabolismo , Electroforesis en Gel de Campo Pulsado , Enterococcus/clasificación , Enterococcus/genética , Transferencia de Gen Horizontal , Infecciones por Bacterias Grampositivas/microbiología , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Péptido Sintasas/genética , Reacción en Cadena de la Polimerasa , Polimorfismo de Longitud del Fragmento de Restricción , Vigilancia de la Población , Vancomicina/farmacología , Resistencia a la Vancomicina/genéticaRESUMEN
Intestinal tract colonization with vancomycin resistant enterococci (VRE) was studied during five months and 25 days. Out of 171 patients hospitalized in the intensive care unit, 124 (73%) were included in this study. Thirty five of them (28%) were recognized as colonized with VRE. VRE isolates (n = 35) were identified as Enterococcus faecium (n = 18), Enterococcus gallinarum (n = 16), and Enterococcus raffinosus (n = 1). All of them were resistant to vancomycin (MIC90 = 512 microg/ml) and to teicoplanin (MIC90 = 32 microg/ml), having the vanA gene. By means of molecular methods a high homology was found among E. faecium and E. gallinarum isolates, respectively, suggesting their spread as a kind of outbreak. No significant differences in age or sex were found among colonized and non-colonized patients (p > 0.05). On the other hand, the hospitalization time and the use of broad-spectrum antibiotics were associated with colonization. From this study we highlight the importance of enhancing all measures of control and prevention of hospital infections, carefully analyzing the empiric antimicrobial schemes, trying to reduce the hospital stage, and following the surveillance to evaluate the efficacy of such procedures.
Asunto(s)
Enterococcus/aislamiento & purificación , Unidades de Cuidados Intensivos , Intestinos/microbiología , Resistencia a la Vancomicina , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Argentina , Estudios de Cohortes , Comorbilidad , ADN Bacteriano/genética , Farmacorresistencia Bacteriana Múltiple , Enterococcus/efectos de los fármacos , Enterococcus/genética , Femenino , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Teicoplanina/farmacología , Vancomicina/farmacologíaRESUMEN
A case of bacteremia due to high-level-vancomycin- (MIC = 64 micrograms/ml) and high-level-teicoplanin- (MIC = 32 micrograms/ml) resistant Enterococcus gallinarum is described. Both genes, van C1 and van A, respectively conferring natural low-level resistance and acquired high-level resistance to vancomycin, were found in the enterococcal genoma. The present is the first report of an E. gallinarum isolate showing the van A genotype in Argentina.
Asunto(s)
Antibacterianos/farmacología , Bacteriemia/microbiología , Farmacorresistencia Bacteriana Múltiple , Enterococcus/aislamiento & purificación , Infecciones por Bacterias Grampositivas/microbiología , Teicoplanina/farmacología , Vancomicina/farmacología , Argentina/epidemiología , Bacteriemia/tratamiento farmacológico , Proteínas Bacterianas/análisis , Proteínas Bacterianas/genética , Ligasas de Carbono-Oxígeno/análisis , Ligasas de Carbono-Oxígeno/genética , Farmacorresistencia Bacteriana Múltiple/genética , Enterococcus/clasificación , Enterococcus/efectos de los fármacos , Enterococcus/genética , Resultado Fatal , Infecciones por Bacterias Grampositivas/tratamiento farmacológico , Humanos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/microbiología , Resistencia a la Vancomicina/genéticaRESUMEN
The advantages of Mycobacteria Growth Indicator Tube (MGIT) system were analyzed and compared to Löwenstein-Jensen (LJ) and Stonebrink (S) solid media when searching for a fast method to diagnose tuberculosis and mycobacterioses, which should be easy to perform in laboratories and of non-invasive reading. All nonsterile specimens were pretreated with Petroff method. A total of 191 specimens were processed (among which 152 were pulmonary and 39 extrapulmonary). Twenty-nine tested positive by one of the methods employed. The rate of recovery of smear positive specimens (ED+) was of 92% with LJ/S, and 85% with MGIT. The mean time to detect a positive result was 18.7 days with MGIT, and 20.6 days with LJ/S. The rate of recovery of smear negative specimens (ED-) was 88.2% with LJ, 70.6% with S, and 23.5% with MGIT. The mean time to detect a positive result were 38.5; 26.5 and 29 days, respectively. During this experiment, MGIT did not seem to have any advantage over the traditional methods, particularly when working with samples containing a low number of bacilli (p < 0.05). It is obviously necessary to make a comparative study with a large amount of cases which might support this observation and to analyze the influence of the reagents employed in the pre-treatment of the specimens on the MGIT system's efficacy to detect mycobacteria.
Asunto(s)
Técnicas Bacteriológicas/instrumentación , Mycobacterium/aislamiento & purificación , Tuberculosis/diagnóstico , Técnicas Bacteriológicas/métodos , Humanos , Sensibilidad y Especificidad , Tuberculosis/microbiologíaRESUMEN
Eikenella corrodens is a gram-negative bacillus that colonizes as normal flora of the mouth, the upper respiratory tract and the gastrointestinal tract. The aim of this study was to determine the susceptibility patterns against fourteen antibiotics of 25 E. corrodens strains isolated at our hospital. MICs were determined by the agar dilution technique using Müeller-Hinton agar with sheep blood (5% v/v) to penicillin, ampicillin, ampicillin-sulbactam, cephalotin, cefoxitin, ceftiaxone, colistin, gentamicin, amikacin, erythromycin, rifampin, ciprofloxacin and clindamycin. The most active antibiotics were ciprofloxacin and ceftriaxone (MIC90 = 0.008 and 0.125 microgram/ml, respectively), whereas eritromycin, gentamicin and amikacin showed less activity. Only one strain was beta lactamase positive, and it was inhibited by sulbactam. Erithromycin, gentamicin and amikacin had poor activity (MIC90 = 16.8 and 64 micrograms/ml, respectively), whereas all the strains were uniformly resistant to clindamycin (MIC > or = 32 micrograms/ml). We suggest about the need of periodical surveys of E. corrodens susceptibility patterns, since strains have been found with decreased susceptibility against antibiotics which are currently being used for the treatment of infectious diseases.
Asunto(s)
Antibacterianos/farmacología , Resistencia a Medicamentos , Eikenella corrodens/efectos de los fármacos , Farmacorresistencia Bacteriana Múltiple , Eikenella corrodens/aislamiento & purificación , Femenino , Infecciones por Bacterias Gramnegativas/microbiología , Humanos , Masculino , Pruebas de Sensibilidad Microbiana/normasRESUMEN
Fifteen episodes of Mycobacterium tuberculosis laboratory cross-contamination suspected between 1996 and 2001 at 6 laboratories in Buenos Aires City and suburbs were investigated by IS6110 RFLP. Thirteen episodes were confirmed. Even though BACTEC 460 produced the highest number of confirmed episodes in a single laboratory, the most extended one occurred while employing conventional culture procedures in solid medium. The double repetitive element-polymerase chain reaction (DRE-PCR) was applied to 8 of these episodes and produced concordant results with those of the RFLP. The DRE-PCR appears to be a valuable tool for the prompt identification of false positive cultures. The timely rectification of defects in laboratory protocols can avert false diagnoses of tuberculosis and unnecessary prolonged treatments.
Asunto(s)
Técnicas Bacteriológicas , ADN Bacteriano/análisis , Contaminación de Equipos , Laboratorios de Hospital , Mycobacterium tuberculosis/aislamiento & purificación , Reacción en Cadena de la Polimerasa/métodos , Polimorfismo de Longitud del Fragmento de Restricción , Tuberculosis/diagnóstico , Aerosoles , Argentina , Técnicas Bacteriológicas/instrumentación , Medios de Cultivo , Reacciones Falso Positivas , Humanos , Radiometría/instrumentación , Manejo de Especímenes , Esterilización/métodosRESUMEN
En un período de cinco meses y 25 días se investigó la portación intestinal de enterococos resistentes a vancomicina (EVR). Se estudiaron 124 pacientes (73%) de 171 admitidos en la unidad de terapia intensiva (UTI), 35 de los cuales (28%) resultaron ser portadores. Los aislamientos de EVR (n=35) fueron identificados como Enterococcus faecium (n=18), Enterococcus gallinarum (n=16) y Enterococcus raffinosus (n=1). Todos los aislamientos estudiados fueron resistentes a vancomicina (VAN) (CIM90= 512 µg/ml) y teicoplanina (CIM90= 32 µg/ml) y portaban el gen vanA. Los estudios de tipificación molecular mostraron un alto grado de homología entre los aislamientos de E. faecium (un clon dominante) y E. gallinarum (dos tipos clonales), sugiriendo su diseminación a modo de brote. No se encontraron diferencias significativas con la edad y el sexo de los pacientes no portadores (p>0,05), pero si con el tiempo de hospitalización y el uso de esquemas antibióticos de amplio espectro (p<0,05), estando estos dos factores asociados al estado de portación. Se deduce de este estudio, la importancia de maximizar las medidas de prevención y control de las infecciones nosocomiales, analizar los esquemas empíricos empleados, tratar de disminuir el tiempo de hospitalización y continuar con los estudios de vigilancia para evaluar la eficacia de las acciones implementadas.
Intestinal tract colonization with vancomycin resistant enterococci (VRE) was studied during five months and 25 days. Out of 171 patients hospitalized in the intensive care unit, 124 (73%) were included in this study. Thirty five of them (28%) were recognized as colonized with VRE. VRE isolates (n = 35) were identified as Enterococcus faecium (n=18), Enterococcus gallinarum (n=16), and Enterococcus raffinosus (n=1). All of them were resistant to vancomycin (MIC90= 512 µg/ml) and to teicoplanin (MIC90= 32 µg/ml), having the vanA gene. By means of molecular methods a high homology was found among E. faecium and E. gallinarum isolates, respectively, suggesting their spread as a kind of outbreak. No significant differences in age or sex were found among colonized and non-colonized patients (p>0.05). On the other hand, the hospitalization time and the use of broad-spectrum antibiotics were associated with colonization. From this study we highlight the importance of enhancing all measures of control and prevention of hospital infections, carefully analyzing the empiric antimicrobial schemes, trying to reduce the hospital stage, and following the surveillance to evaluate the efficacy of such procedures.
Asunto(s)
Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Enterococcus/aislamiento & purificación , Unidades de Cuidados Intensivos , Intestinos/microbiología , Resistencia a la Vancomicina , Argentina , Estudios de Cohortes , Comorbilidad , ADN Bacteriano/genética , Farmacorresistencia Bacteriana Múltiple , Enterococcus/efectos de los fármacos , Enterococcus/genética , Genotipo , Estudios Prospectivos , Teicoplanina/farmacología , Vancomicina/farmacologíaAsunto(s)
Infecciones por Mycobacterium no Tuberculosas , Micobacterias no Tuberculosas/aislamiento & purificación , Tuberculosis Osteoarticular/microbiología , Muñeca , Síndrome del Túnel Carpiano/cirugía , Femenino , Fístula/etiología , Humanos , Persona de Mediana Edad , Infecciones por Mycobacterium no Tuberculosas/diagnóstico , Infecciones por Mycobacterium no Tuberculosas/diagnóstico por imagen , Osteólisis/diagnóstico por imagen , Osteólisis/etiología , Radiografía , Enfermedades de la Piel/etiología , Infección de la Herida Quirúrgica/microbiologíaRESUMEN
The advantages of Mycobacteria Growth Indicator Tube (MGIT) system were analyzed and compared to L÷wenstein-Jensen (LJ) and Stonebrink (S) solid media when searching for a fast method to diagnose tuberculosis and mycobacterioses, which should be easy to perform in laboratories and of non-invasive reading. All nonsterile specimens were pretreated with Petroff method. A total of 191 specimens were processed (among which 152 were pulmonary and 39 extrapulmonary). Twenty-nine tested positive by one of the methods employed. The rate of recovery of smear positive specimens (ED+) was of 92 with LJ/S, and 85 with MGIT. The mean time to detect a positive result was 18.7 days with MGIT, and 20.6 days with LJ/S. The rate of recovery of smear negative specimens (ED-) was 88.2 with LJ, 70.6 with S, and 23.5 with MGIT. The mean time to detect a positive result were 38.5; 26.5 and 29 days, respectively. During this experiment, MGIT did not seem to have any advantage over the traditional methods, particularly when working with samples containing a low number of bacilli (p < 0.05). It is obviously necessary to make a comparative study with a large amount of cases which might support this observation and to analyze the influence of the reagents employed in the pre-treatment of the specimens on the MGIT system's efficacy to detect mycobacteria.
Asunto(s)
Humanos , Mycobacterium , Técnicas Bacteriológicas/instrumentación , Tuberculosis , Sensibilidad y Especificidad , Técnicas Bacteriológicas/métodos , TuberculosisRESUMEN
En este trabajo se presenta un caso de bacteriemia por Enterococcus gallinarum con resistencia a altos niveles de vancomicina (CIM=ug/ml) y teicoplanina (CIM=32 ug/ml), coincidentes con el fenotipo Van A. Se comprobó que esta bacteria, además de contener el gen van C1 propio de la especie, que le confiere resistencia natural a bajos niveles de vancomicina, también era portadora del gen van A. Esta es la notificación del primer aislamiento clínico de E.gallinarum portador del genotipo van A en la Argentina.
Asunto(s)
Antibacterianos , Argentina , Bacteriemia , Farmacorresistencia Microbiana , Enterococcus , Vancomicina , Resistencia a la VancomicinaRESUMEN
Eikenella corrodens is a gram-negative bacillus that colonizes as normal flora of the mouth, the upper respiratory tract and the gastrointestinal tract. The aim of this study was to determine the susceptibility patterns against fourteen antibiotics of 25 E. corrodens strains isolated at our hospital. MICs were determined by the agar dilution technique using M³eller-Hinton agar with sheep blood (5
v/v) to penicillin, ampicillin, ampicillin-sulbactam, cephalotin, cefoxitin, ceftiaxone, colistin, gentamicin, amikacin, erythromycin, rifampin, ciprofloxacin and clindamycin. The most active antibiotics were ciprofloxacin and ceftriaxone (MIC90 = 0.008 and 0.125 microgram/ml, respectively), whereas eritromycin, gentamicin and amikacin showed less activity. Only one strain was beta lactamase positive, and it was inhibited by sulbactam. Erithromycin, gentamicin and amikacin had poor activity (MIC90 = 16.8 and 64 micrograms/ml, respectively), whereas all the strains were uniformly resistant to clindamycin (MIC > or = 32 micrograms/ml). We suggest about the need of periodical surveys of E. corrodens susceptibility patterns, since strains have been found with decreased susceptibility against antibiotics which are currently being used for the treatment of infectious diseases.
RESUMEN
Fifteen episodes of Mycobacterium tuberculosis laboratory cross-contamination suspected between 1996 and 2001 at 6 laboratories in Buenos Aires City and suburbs were investigated by IS6110 RFLP. Thirteen episodes were confirmed. Even though BACTEC 460 produced the highest number of confirmed episodes in a single laboratory, the most extended one occurred while employing conventional culture procedures in solid medium. The double repetitive element-polymerase chain reaction (DRE-PCR) was applied to 8 of these episodes and produced concordant results with those of the RFLP. The DRE-PCR appears to be a valuable tool for the prompt identification of false positive cultures. The timely rectification of defects in laboratory protocols can avert false diagnoses of tuberculosis and unnecessary prolonged treatments.